Effect of PGE2 on the cell surface molecule expression in PMA treated thymocytes
Related Experiment Video
Updated: Oct 30, 2026

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
R Daculsi1, D Vaillier, J C Carron
1CNRS UMR 5540, Université Victor Segalen Bordeaux 2, France.
Abstract:
PGE2 is produced by cells of the thymic microenvironment. The effects of PGE2 are mediated by cAMP through binding to its intracellular receptor protein kinase A (PKA). Phorbol 12-myristate 13-acetate (PMA) is known to modulate CD molecule expression on thymocytes, probably through activation of protein kinase C (PKC). We have hypothesized that cross-talk between these two signalling pathways may affect modulation of the CD molecules on the cell surface of thymocytes. For this purpose, we compare the effects of PMA alone or combined with PGE2 on CD3, CD4 and CD8 expression on mouse thymocytes by flow-cytometric analysis. PMA treatment almost completely abolished CD4 expression and slightly decreased CD3 and CD8 expression. PGE2 alone did not change the CD3, CD4 and CD8 molecule expression. Combined with PMA, PGE2 can overcome the decrease induced by PMA of the CD3 expression and partially reduced the disappearance of the CD4 molecule. On the other hand PGE2 accelerated the loss of CD8 molecule expression. These events occurred only in CD4+ CD8+ immature thymocytes. An analogue of cAMP (dibutyryl cAMP) mimics the effect of PGE2, but not Br-cGMP. This differential regulation by PGE2 of the CD molecule expression on immature thymocytes may provide additional evidence on the role of PGE2 during the process of thymic differentiation.
Insights
Prostaglandin E2 (PGE2) interacts with protein kinase C (PKC) pathways to influence thymocyte differentiation. PGE2 modulates CD molecule expression, impacting T-cell development in the thymus.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Prostaglandin E2 (PGE2) is produced in the thymus and signals via cyclic AMP (cAMP) and protein kinase A (PKA).
- Phorbol 12-myristate 13-acetate (PMA) affects thymocyte CD molecule expression through protein kinase C (PKC).
- Potential cross-talk between PGE2/PKA and PMA/PKC pathways in thymocytes is unexplored.
Purpose of the Study:
- To investigate the interaction between PGE2 and PMA signaling pathways.
- To determine how this cross-talk affects CD3, CD4, and CD8 expression on thymocytes.
- To elucidate the role of PGE2 in thymic differentiation.
Main Methods:
- Flow cytometric analysis of mouse thymocytes.
- Treatment with PMA alone and in combination with PGE2.
- Comparison of CD3, CD4, and CD8 expression levels.
Main Results:
- PMA significantly decreased CD4 expression and slightly reduced CD3 and CD8 expression.
- PGE2 alone did not alter CD3, CD4, or CD8 expression.
- PGE2 counteracted PMA-induced CD3 decrease, partially restored CD4 expression, but accelerated CD8 loss in CD4+CD8+ thymocytes.
- Dibutyryl cAMP mimicked PGE2 effects, while Br-cGMP did not.
Conclusions:
- PGE2 differentially regulates CD molecule expression on immature thymocytes.
- Cross-talk between PGE2 and PMA pathways influences thymocyte differentiation.
- PGE2 plays a significant role in regulating thymic T-cell development.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Cell Specific Gene Expression
GPCRs Regulate Adenylyl Cylase Activity
Two...